✦ LIBER ✦

Effect of Teduglutide on Patients With Moderate-Severe Crohn’s Disease After 8 Weeks of Therapy: A Prospective, Double-Blind, Placebo-Controlled Trial

✍ Scribed by A.L. Buchman; S. Katz; M. Shnaidman; D. Jacobs

Book ID: 119759394
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 65 KB
Volume: 131
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2006.06.097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn’s disease

✍ J. C. MANSFIELD; M. PARKES; A. B. HAWTHORNE; A. FORBES; C. S. J. PROBERT; R.C. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

Secukinumab, a human anti-IL-17A monoclo

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

✍ Hueber, W.; Sands, B. E.; Lewitzky, S.; Vandemeulebroecke, M.; Reinisch, W.; Hig 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 304 KB

Effect of intravenous immunoglobulin on

Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: A double-blind, placebo-controlled, randomized trial

✍ Salmun, Luis M.; Barlan, Isil; Wolf, Hermann M.; Eibl, Martha; Twarog, Frank J.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Restoration of muscle strength after nut

Restoration of muscle strength after nutritional supplementation in patients with Crohn's disease in a double blind placebo controlled study

✍ Geerling, B.J.; van Deursen, C.; Stockbrügger, R.W.; Brummer, R-J.M. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 182 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of safinamide as add-on therapy in early Parkinson's disease patients

✍ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to

Long-term efficacy and safety results (6

Long-term efficacy and safety results (60 weeks) of a double-blind, placebo-controlled, crossover trial of infliximab for patients with moderate to severe hidradenitis suppurativa

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 41 KB